advisorsecurities master

NRXSNeuraxis, Inc.

CSNYSE American, LLC (XASE)·USD

Identity

Security key
19315
Ticker
NRXS
Type
CSCommon Stock
Exchange
NYSE American, LLC(XASE)
Venue group
NYSE
Operating MIC
XNYS
Market
stocks
Locale
us
Currency
USD
Listed
2023-08-09
Round lot
100
Active
Yes
Last seen in a load
2026-08-14 20:49
Vendor updated
2026-08-13 06:09
Ticker root / suffix
NRXS

Detail

Enriched 2026-08-14 20:47

Market cap
$78,737,186.55
Shares outstanding (class)
12,477,309
Shares outstanding (weighted)
12,557,765
SIC
3845 ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
Employees
24
Location
CARMEL, IN
Description

Neuraxis Inc is a growth-stage medical technology company focused on neuromodulation therapies for chronic and debilitating conditions in the gastrointestinal (GI) digestive system, specifically from disorders of the gut-brain interaction (DGBIs) in pediatrics and adults. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).

Market cap and share counts drift.

Funds holding this security

Identifiers

Classification

Fund data